1 of 2
Story summary
- UK negotiates with the Trump administration to raise National Health Service (NHS) drug pricing up to 25% to avoid tariffs.
- National Institute for Health and Care Excellence (NICE) would raise its threshold from £20,000-£30,000 to £50,000 per additional year of life.
- Critics warn the higher price could trigger NHS budget cuts and delay care, with pharma firms pausing UK investments.
1 / 2
